Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Novartis launch NET cancer community app

Galaxies of Hope aims to provide support to cancer patients

Galaxies of HopeFollowing its release of a remote clinical trial app, Novartis has honed in on digital once again, this time launching an app designed to support the Neuroendocrine Tumour (NET) cancer community.

NET is a type of cancer that develops from cells that specifically produce and secrete a variety of hormones that regulate bodily functions.

There are several types of NET cancers that can occur throughout the body, but most are found in the gastrointestinal tract, pancreas and lungs.

Novartis, which said that raising awareness of NET cancer is important in improving understanding and management of this rare disease, has launched Galaxies of Hope as an aid to this.

The app engages users through visual storytelling, using the real voices of patients, caregivers and physicians.

Ameet Mallik, executive vice president and head of US oncology at Novartis, said: We believe that this app can have a real, positive impact in the NET cancer community and we hope the creation of this virtual patient journey experience for the NET cancer community will provide support to those living with this rare disease and those who manage and care for them.”

The app will be available for download in the US on the Google Play Store.

Article by
Gemma Jones

17th July 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Top Pharma News

TopPharmaNews.com is a global pharma magazine dedicated to delivering fresh news to society. The team at the TopPharmaNews.com cater non-biased,...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics